IFNG and neoplasm: T cells are activated in the local region of tumor and thus secrete IFN-γ [24–26], which can subsequently induce upregulation of PD-L1 in tumor cells and immune cells in the microenvironment [11, 27], thereby inhibiting tumor eradication led by T cells.